Bergenia crassifolia
Bergenia crassifolia · Accepted scientific name
Scientific literature: Very Sparse (14 studies) · ★☆☆☆☆
Bergenia crassifolia is a significant medicinal plant known for the therapeutic potential found within its rhizome. Scientific investigations have focused on the crude ethanolic extracts of this species to uncover various pharmacological benefits. A primary chemical constituent of interest in these studies is bergenin, which contributes to the plant's diverse biological profile. Research indicates that the plant exhibits powerful anticancer, antiarrhythmic, antiarthritic, and antibacterial activities. Furthermore, it demonstrates promising antioxidant, antiviral, and antimalarial properties, including effectiveness against Bacillus cereus.
- Synonyms
- Megasea Crassifolia · Saxifraga Crassifolia · 1 more
- Common names
- Not available
- Family
- Saxifragaceae
- Distribution
- Northern America
- Plant Parts
- Rhizome
Classification
Common Names
Bergenia crassifolia is a versatile plant known by several different names across various regions and languages. It is frequently referred to by its common moniker, Bergenia grubolistna, or simply as Bergenie. In French-speaking contexts, you may encounter it called Bergénie à feuilles charnues to describe its succulent nature. Some enthusiasts also recognize the species as Clustiau Eliffant, adding a unique local flavor to its identity. Finally, the plant is widely documented under the name Dickblatt-Bergenie in botanical circles.
Sources: Catalogue of Life (COL)
Synonyms
Bergenia crassifolia is a botanical species that is frequently identified by various alternative names in scientific literature. Due to historical taxonomic shifts, this plant is recognized under the synonym Geryonia crassifolia. It is also documented in botanical records as Megasea crassifolia. Furthermore, researchers may encounter the name Saxifraga crassifolia when studying its classification. Understanding these overlapping synonyms is essential for accurate identification and consistent research within the field.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Bergenia crassifolia is a distinctive member of the kingdom Plantae. Within this vast biological realm, the plant is classified under the class Equisetopsida. It belongs to the order Saxifragales, which helps define its evolutionary lineage. Further narrowing its identity, the species is a part of the Saxifragaceae family. Finally, it is categorized under the specific genus Bergenia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Saxifragales |
| Family | Saxifragaceae |
| Genus | Bergenia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Bergenia crassifolia is a resilient species widely distributed across the temperate regions of Asia. Its natural range stretches through the vast landscapes of Central Asia, specifically within Kazakhstan. The plant is also well-established in parts of China, notably within the Xinjiang region. Further east, it can be found throughout Eastern Asia, including the Korean peninsula and Mongolia. Additionally, its presence extends into the Russian Far East, particularly within the Amur region.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Bergenia crassifolia is a self-supporting herb that maintains a sturdy, upright structure in its natural habitat. This resilient plant typically grows to a modest height, generally staying well below 0.6 meters. Depending on environmental conditions, its stature can vary significantly, with some specimens measuring as little as 0.06 meters. Such compact growth makes it a charming addition to various landscapes.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Bergenia crassifolia is a medicinal plant that serves as a significant natural source of the bioactive molecule bergenin. Research indicates that bergenin possesses a wide range of pharmacological properties, including notable antibacterial and antifungal activities. Furthermore, the compound has demonstrated potential in treating chronic conditions through its antiarthritic and antiarrhythmic effects. Recent computational studies have also highlighted its promising anticancer activity, specifically through its ability to target galectin-3. Because these activities are observed without cytotoxicity to healthy cells, the plant remains a highly promising subject for modern drug development.
Compounds
Bergenia crassifolia is a medicinal plant recognized for its significant phytochemical properties, most notably for containing the compound bergenin. This natural C-glycoside was originally discovered within the rhizomes of the plant and has since gained widespread scientific interest. Bergenin is highly valued for its diverse pharmacological activities, including potent antioxidant, anti-inflammatory, and antimicrobial effects. Recent research has specifically highlighted its promising potential as an anticancer agent due to its ability to target key proteins involved in tumor progression. Because bergenin has shown no toxicity to healthy cells, it remains a highly attractive scaffold for developing safer, more effective therapeutic treatments.
Conditions
Bergenia crassifolia demonstrates significant antimicrobial activity against a variety of tested microorganisms. Specifically, the plant's extracts effectively treat the bacterium Bacillus cereus. It also shows the ability to treat the fungal pathogen Candida albicans. Furthermore, the plant acts against the harmful bacteria Escherichia coli and Pseudomonas aeruginosa. Finally, Bergenia crassifolia serves as an effective treatment for Staphylococcus aureus.
Preparations
Bergenia crassifolia is prepared as crude ethanolic extracts for antimicrobial testing. These specific extracts were evaluated against five distinct species of microorganisms to determine their biological effectiveness. During the screening of Siberian medicinal plants, this particular preparation demonstrated significant antimicrobial activity. It emerged as one of the most active plants among the sixteen species tested in the study. Consequently, the ethanolic extract of Bergenia crassifolia showed potency against pathogens such as Bacillus cereus and Escherichia coli.
Parts used
Bergenia crassifolia is a medicinal plant that serves as a significant source of the glycosidic derivative known as bergenin. This bioactive compound was originally discovered within the plant's rhizome, marking the beginning of extensive pharmacological research. Due to its presence in these underground structures, the species has become a focal point for studying various therapeutic properties. Researchers have identified a wide range of beneficial activities in bergenin, including antioxidant and anti-inflammatory effects. Consequently, the unique relationship between this plant and its rhizome continues to drive interest in developing new medical treatments.